We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$231M
AUM Growth
-$3.86M
Cap. Flow
-$2.84M
Cap. Flow %
-1.23%
Top 10 Hldgs %
35.2%
Holding
100
New
1
Increased
14
Reduced
55
Closed
7

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$1.13M
2
DHR icon
Danaher
DHR
+$858K
3
CB icon
Chubb
CB
+$540K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443K
5
SJM icon
J.M. Smucker
SJM
+$441K

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$1.66M
2
UL icon
Unilever
UL
+$669K
3
JCI icon
Johnson Controls International
JCI
+$465K
4
KR icon
Kroger
KR
+$380K
5
CSCO icon
Cisco
CSCO
+$328K

Sector Composition

Rank Sector Weight
1 Healthcare 23.25%
2 Technology 20.64%
3 Industrials 17.24%
4 Consumer Staples 9.36%
5 Energy 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$604B
$9.9M 4.29%
85,991
-935
-1% -$108K
PG icon
2
Procter & Gamble
PG
$348B
$9.76M 4.23%
116,104
-1,132
-1% -$96.5K
MMM icon
3
3M
MMM
$84.1B
$9.45M 4.09%
63,260
-324
-0.5% -$46.8K
ADP icon
4
Automatic Data Processing
ADP
$102B
$8.7M 3.77%
84,660
-1,023
-1% -$95.4K
XOM icon
5
ExxonMobil
XOM
$616B
$8.26M 3.58%
91,519
+373
+0.4% +$32.6K
CNI icon
6
Canadian National Railway
CNI
$77.6B
$7.44M 3.23%
110,450
-434
-0.4% -$28.6K
ATR icon
7
AptarGroup
ATR
$8.31B
$7.12M 3.08%
96,920
+1,765
+2% +$131K
CVS icon
8
CVS Health
CVS
$137B
$7.01M 3.04%
88,816
-1,840
-2% -$149K
AAPL icon
9
Apple
AAPL
$4.78T
$6.64M 2.88%
229,384
-2,356
-1% -$66.8K
NVS icon
10
Novartis
NVS
$289B
$6.46M 2.8%
98,940
-536
-0.5% -$34.8K
HD icon
11
Home Depot
HD
$332B
$6.29M 2.73%
46,913
-595
-1% -$76.7K
MA icon
12
Mastercard
MA
$483B
$6.25M 2.71%
60,530
+2,270
+4% +$235K
FISV
13
Fiserv Inc
FISV
$27.7B
$6.2M 2.69%
116,640
-1,300
-1% -$66.8K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.34T
$5.93M 2.57%
149,560
+11,080
+8% +$443K
INTC icon
15
Intel
INTC
$498B
$5.79M 2.51%
159,632
-800
-0.5% -$28.6K
ROK icon
16
Rockwell Automation
ROK
$51.5B
$5.06M 2.19%
37,634
-100
-0.3% -$12.8K
CB icon
17
Chubb
CB
$137B
$4.88M 2.12%
36,975
+4,235
+13% +$540K
ABT icon
18
Abbott
ABT
$177B
$4.23M 1.83%
110,015
+1,015
+0.9% +$40.2K
XLNX
19
DELISTED
Xilinx Inc
XLNX
$4.14M 1.79%
68,645
-315
-0.5% -$16.9K
RTX icon
20
RTX Corp
RTX
$266B
$4.06M 1.76%
58,879
+3,711
+7% +$246K
PEP icon
21
PepsiCo
PEP
$184B
$3.86M 1.67%
36,878
-675
-2% -$70.7K
ORCL icon
22
Oracle
ORCL
$353B
$3.8M 1.65%
98,867
-650
-0.7% -$25.4K
NXPI icon
23
NXP Semiconductors
NXPI
$68.8B
$3.44M 1.49%
35,040
DHR icon
24
Danaher
DHR
$143B
$3.24M 1.4%
46,909
+12,363
+36% +$858K
GE icon
25
GE Aerospace
GE
$357B
$3.17M 1.37%
20,932
-148
-0.7% -$21.5K

Similar funds

Brian C. Broderick's Q4 2016 Portfolio in Review

As of Q4 2016, Brian C. Broderick held 100 positions worth $231M, down 1.6% from $235M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brian C. Broderick's Q4 2016 filing shows 1 new, 14 increased, 55 reduced and 7 closed positions. Its largest new stake was Royal Bank of Canada: 3,000 shares worth $203K. The largest sale was Target, an estimated $1.66M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q4 2016 buy was Royal Bank of Canada: 3,000 shares worth $203K.
  • Brian C. Broderick added most to Analog Devices in Q4 2016, an estimated $1.13M increase.
  • Brian C. Broderick's biggest Q4 2016 reduction was Target, cutting an estimated $1.66M.
  • Brian C. Broderick fully exited Johnson Controls International in Q4 2016, selling an estimated $465K.
  • Brian C. Broderick's ten largest holdings make up 35% of its $231M portfolio in Q4 2016.
  • Brian C. Broderick opened 1 new position and closed 7 in Q4 2016.
  • Brian C. Broderick's portfolio value fell 1.6% quarter-over-quarter to $231M.

Based on Brian C. Broderick's 13F filing for Q4 2016, filed 14 Feb 2017.